Evaluation of the Efficacy and Safety of Darolutamide + ADT Combined With Low-dose Docetaxel in mHSPC
Clinical trial NCT07503379 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07503379
- Sponsor
- Yonghong Li
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2027-12-01
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.